Coloplast A/S (XSWX:COLOB)
CHF 115 0 (0%) Market Cap: 22.64 Bil Enterprise Value: 25.50 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 91/100

Q2 2020 Coloplast A/S Earnings Call Transcript

May 06, 2020 / 01:00PM GMT
Release Date Price: CHF111
Operator

Thank you, speakers. Your line is now open. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Good afternoon, everybody. And welcome to our second quarter '19/'20 conference call. I am Kristian Villumsen, CEO of Coloplast, and I'm joined by CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll run the call like we usually do, where we start with a short presentation by Anders and myself and then open up for questions.

We've had significant technical difficulties at our conference center. So at this stage, we believe that not all the people who have wanted to attend the call can attend. So of course, the call will -- is available post the meeting, and we will do our best to make ourselves available for follow-up questions from anyone who wishes to get in contact with the company.

Please turn to Slide #3. Coloplast delivered a strong set of numbers in the second quarter with 9% organic growth, a 15% increase in EBIT and a return on invested capital of 46%. The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot